disodium [3S-(3alpha,4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionato(4-)-N23,N24,N25,N26]cuprate(2-)
disodium [3S-(3alpha,4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionato(4-)-N23,N24,N25,N26]cuprate(2-)
CAS: 73836-75-6
Molecular Formula: C34H28CuN4Na2O6
disodium [3S-(3alpha,4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionato(4-)-N23,N24,N25,N26]cuprate(2-) - Names and Identifiers
disodium [3S-(3alpha,4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionato(4-)-N23,N24,N25,N26]cuprate(2-) - Physico-chemical Properties
| Molecular Formula | C34H28CuN4Na2O6 |
| Molar Mass | 698.13486 |
disodium [3S-(3alpha,4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionato(4-)-N23,N24,N25,N26]cuprate(2-) - Introduction
Diodium [3S-(3Alpha, 4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8, (4-)-N23,N24,N25,N26]cuprate(2-) is a compound whose chemical formula is C42H41CuN4Na2O8.
Nature:
The compound is a dark red or brown-red crystal, soluble in water and ethanol. It has a certain photosensitivity, can be excited by light and chemical reaction.
Use:
The compound has certain applications in the field of biomedicine. It can be used as a photosensitizer for photodynamic therapy, that is, by activating the compound and generating the active substance under light, in the treatment of some tumors and skin lesions.
Preparation Method:
The preparation method of this compound is relatively complicated and usually requires multiple steps to synthesize. The main steps include the synthesis of Poly methyl porphyrin, ethynylation, synthesis of the corresponding ethylene diamine hydrochloride, etc.
Safety Information:
The safety information on this compound is limited, so it should be handled with caution and in accordance with relevant safety procedures. Due to its photosensitive nature, prolonged exposure to strong light should be avoided. Care should be taken during handling and storage to avoid contact with skin and eyes, and to avoid inhalation or ingestion. If accidental exposure occurs, immediately flush the affected area with adequate water and seek medical help. Use and handle the compound only under professional guidance.
Nature:
The compound is a dark red or brown-red crystal, soluble in water and ethanol. It has a certain photosensitivity, can be excited by light and chemical reaction.
Use:
The compound has certain applications in the field of biomedicine. It can be used as a photosensitizer for photodynamic therapy, that is, by activating the compound and generating the active substance under light, in the treatment of some tumors and skin lesions.
Preparation Method:
The preparation method of this compound is relatively complicated and usually requires multiple steps to synthesize. The main steps include the synthesis of Poly methyl porphyrin, ethynylation, synthesis of the corresponding ethylene diamine hydrochloride, etc.
Safety Information:
The safety information on this compound is limited, so it should be handled with caution and in accordance with relevant safety procedures. Due to its photosensitive nature, prolonged exposure to strong light should be avoided. Care should be taken during handling and storage to avoid contact with skin and eyes, and to avoid inhalation or ingestion. If accidental exposure occurs, immediately flush the affected area with adequate water and seek medical help. Use and handle the compound only under professional guidance.
Last Update：2024-04-10 22:29:15
![disodium [3S-(3alpha,4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionato(4-)-N23,N24,N25,N26]cuprate(2-)](http://res.chembk.com/assets/images/structure/73836-75-6.gif)
Supplier List
View History
disodium [3S-(3alpha,4beta,21beta)]-[21-carboxy-14-ethyl-13-formyl-4,8,18-trimethyl-20-oxo-9-vinylphorbine-3-propionato(4-)-N23,N24,N25,N26]cuprate(2-)
5-methyl-2-[(5-methylthiophene-2-)sulfonamido]benzoic acid
3-Pyrrolidinecarboxylic acid, 5-ethenyl-2-oxo-
N-[2-(Diethylamino)ethyl]-N-octyl-2-pyridinamine
93284-42-5
2-[2-(3-chlorophenyl)-2-oxoethylidene]-1,3-thiazolidin-4-one
8a(2H)-Phenanthrenol, 7-ethenyldodecahydro-1,1,4a,7-tetramethyl-, (4aS,4bR,7S,8aR,10aS)-
2-(3-((Dimethylamino)methyl)phenyl)acetic acid
Glycyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-argininamide
887440-34-8
5-methyl-2-[(5-methylthiophene-2-)sulfonamido]benzoic acid
3-Pyrrolidinecarboxylic acid, 5-ethenyl-2-oxo-
N-[2-(Diethylamino)ethyl]-N-octyl-2-pyridinamine
93284-42-5
2-[2-(3-chlorophenyl)-2-oxoethylidene]-1,3-thiazolidin-4-one
8a(2H)-Phenanthrenol, 7-ethenyldodecahydro-1,1,4a,7-tetramethyl-, (4aS,4bR,7S,8aR,10aS)-
2-(3-((Dimethylamino)methyl)phenyl)acetic acid
Glycyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-argininamide
887440-34-8